EUS-Guided Radiofrequency Ablation as a Minimally Invasive Treatment for Insulinomas—A Single-Center Experience
EUS-RFA appears to provide complete symptom resolution and demonstrates a favorable safety profile compared to conventional surgery. However, the long-term efficacy of EUS-RFA remains to be determined.
Authors
- Mie Sonne
- Ulrich Knigge (ORCID: https://orcid.org/0000-0001-5930-0903)
- Peter Vilmann (ORCID: https://orcid.org/0000-0001-7889-1104)
- Marianne Klose (ORCID: https://orcid.org/0000-0001-6075-0821)
- Mikkel Andreassen (ORCID: https://orcid.org/0000-0002-1656-3516)
- Bojan Kovacevic (ORCID: https://orcid.org/0000-0003-3941-0544)
- Lene Brink (ORCID: https://orcid.org/0000-0002-0515-4602)
Institutions
- University of Copenhagen (DK)
- Herlev Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-10-19
- DOI
- https://doi.org/10.1210/clinem/dgaf571
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35